<document id="DDI-DrugBank.d388">
    <sentence id="DDI-DrugBank.d388.s1" text="Patients treated with acebutolol plus catecholamine depletors should, therefore, be observed closely for evidence of marked bradycardia or hypotension which may present as vertigo, syncope/presyncope, or orthostatic changes in blood pressure without compensatory tachycardia.">
        <entity charOffset="22-31" id="DDI-DrugBank.d388.s1.e0" text="acebutolol" type="drug" />
        <entity charOffset="38-60" id="DDI-DrugBank.d388.s1.e1" text="catecholamine depletors" type="group" />
        <pair ddi="true" e1="DDI-DrugBank.d388.s1.e0" e2="DDI-DrugBank.d388.s1.e1" id="DDI-DrugBank.d388.s1.p0" type="advise" />
    </sentence>
    <sentence id="DDI-DrugBank.d388.s2" text="Exaggerated hypertensive responses have been reported from the combined use of beta-adrenergic antagonists and alpha-adrenergic stimulants, including those contained in proprietary cold remedies and vasoconstrictive nasal drops.">
        <entity charOffset="79-105" id="DDI-DrugBank.d388.s2.e0" text="beta-adrenergic antagonists" type="group" />
        <entity charOffset="111-137" id="DDI-DrugBank.d388.s2.e1" text="alpha-adrenergic stimulants" type="group" />
        <pair ddi="true" e1="DDI-DrugBank.d388.s2.e0" e2="DDI-DrugBank.d388.s2.e1" id="DDI-DrugBank.d388.s2.p0" type="effect" />
    </sentence>
    <sentence id="DDI-DrugBank.d388.s4" text="Blunting of the antihypertensive effect of beta-adrenoceptor blocking agents by nonsteroidal anti-inflammatory drugs has been reported.">
        <entity charOffset="43-75" id="DDI-DrugBank.d388.s4.e0" text="beta-adrenoceptor blocking agents" type="group" />
        <entity charOffset="80-115" id="DDI-DrugBank.d388.s4.e1" text="nonsteroidal anti-inflammatory drugs" type="group" />
        <pair ddi="true" e1="DDI-DrugBank.d388.s4.e0" e2="DDI-DrugBank.d388.s4.e1" id="DDI-DrugBank.d388.s4.p0" type="effect" />
    </sentence>
    </document>